Inventage Lab, Yuhan to co-work for obesity treatment
South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting inj...
LG to inject $700 million in startups in West Virginia
CHARLESTON, WV – LG Electronics Inc. will form a fund with the State of West Virginia to inject $700 million over the next five years to foste...
Digital healthcare, robot, AI chip startups among VCs’ 2024 top picks
Startups that specialize in digital healthcare, robots and artificial intelligence chips are among South Korea-based venture capital firms’ to...
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
HS Ad, Coupang to co-work for retail media advertising
South Korea’s HS Ad Inc. announced on Thursday that it will collaborate with the domestic e-commerce giant Coupang for data-based digital mark...
Boryung, HK inno.N to co-market Kanarb, K-CAB
South Korea’s pharmaceutical companies Boryung Corp. and HK inno.N announced on Wednesday that they will start co-marketing for their respec...
DL E&C, KBR to co-work for SAF project
South Korea’s DL E&C Co. announced on Wednesday that it signed a feasibility study contract with Kellogg Brown & Root (KBR) Inc., the ...
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Celltrion, Cyron to develop multi-specific antibody new drug
South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...
Lotte Chilsung, E&J Gallo to jointly boost soju sale in US
South Korea’s Lotte Chilsung Beverage Co. announced on Tuesday that it partnered with the world's largest winery E&J Gallo to expand its...
Hyungji, Dishang Group to co-work for market development
South Korea’s Fashion Group Hyungji and China’s largest clothing exporter Dishang Group signed a memorandum of understanding (MOU) to te...
Celltrion Healthcare's Remsima SC to be launched in US in 2024
Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...
Samsung sets up future business planning unit, keeps co-CEO system
Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, is creating a new division tasked with working out future ...
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
SK C&C to promote AI healthcare for brain diseases
South Korea's SK C&C announced on Thursday that it signed a strategic business agreement with Neurophet, a cloud-based AI platform for brain ima...
S.Korean aerospace firms to co-work for SLV
South Korea's aerospace companies will collaborate to secure launch vehicle technology for small satellites weighing less than 500kg. The Sou...
Hanyang, Air Products to co-work for green ammonia
South Korea's Hanyang Corporation announced on Thursday it signed a memorandum of understanding (MOU) with the US industrial gas company Air Product...
Fed rate likely to be 2-4% over next decade: Oaktree's Howard Marks
Investors are experiencing the third “sea change,” facing the Federal Reserve’s rate hikes and its impact on economies and busines...
WeWork vs Starbucks as workspace in South Korea
In 2019, WeWork’s business model underwent a reality check.Its application for an initial public offering the same year was met with investor ...
Celltrion to supply Remsima to Brazil gov’t in three-year row
South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...
Celltrion enjoys record earnings on healthy biosimilar biz
South Korean pharmaceutical giant Celltrion Inc. logged record quarterly earnings on the strong performance of its key biosimilar products while exp...
Neowiz, SK Hynix to team up for global marketing
South Korean game developer Neowiz announced on Friday it has signed a memorandum of understanding (MOU) with SK Hynix Inc. for global marketing col...
Ex-Kumho Petrochemical chair returns as Kumho Mitsui co-CEO
Park Chan-koo, former chairman of South Korea’s Kumho Petrochemical Group, has returned to the top position of Kumho Mitsui Chemicals Inc. as ...
Naver-invested ichrogene enters Thai market
South Korea's digital healthcare startup ichrogene, with investment from Naver D2 Startup Factory (D2SF), entered into Thai market. Naver Corp....
SK Innovation, ENEOS to co-work for low-carbon energy
SK Innovation Co. said on Wednesday it will bolster its alliance with Japan's largest petroleum refiner ENEOS. This decision builds on their histor...
S.Korea's SKC to sell fine ceramic business for $270 mn
South Korea's SKC Ltd. announced on Tuesday it will sell the fine ceramics business of its subsidiary SK enpulse, a semiconductor materials investme...
SK Square in talks with Qoo10 for joint management of 11Street
SK Square Co., the investment management arm of SK Group, is in talks with Qoo10 Pte. to merge its e-commerce subsidiary 11Street with the Singapore...
LG Elec to launch new business with startup: LG NOVA head
SAN FRANCISCO – LG Electronics Inc. will set up a new business entity focusing on some of its new growth pillars — digital healthcare, c...
